MetaCap

Cardinal Health (CAH) vs Cencora (COR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cardinal Health (CAH) has outperformed Cencora (COR) over the past year, gaining 30.2% versus a loss of 7.3%. Over five years, CAH leads with a +473.1% price change compared with +182.0% for COR. Cencora is the larger company by market cap ($64.71 billion vs $63.06 billion), about 1.0 times the size, while Cardinal Health is growing revenue faster (+14.2% vs +9.3%).

On valuation, Cencora trades at a lower forward P/E (15.6x vs 18.9x for Cardinal Health). Cardinal Health offers the higher dividend yield (0.75% vs 0.71%). Cardinal Health converts more of its revenue into profit, with a net margin of 0.7% versus 0.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CAH+30.23%COR-7.27%
+39%+2%-34%
Nov 21, 20251 yearNov 20, 2026
CAH+463.19%COR+181.36%
+504%+239%-27%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CAH versus COR key metrics
MetricCAHCOR
Share price$272.81$339.09
Market cap$63.06B$64.71B
1-day change+0.17%-0.63%
YTD return+32.75%+0.40%
1-year return+30.23%-7.27%
5-year return+473.13%+182.03%
P/E ratio (TTM)35.2918.89
Forward P/E18.8915.60
EPS (TTM)$7.73$17.95
Dividend yield0.75%0.71%
Annual dividend$2.05$2.40
Revenue (latest FY)$254.25B$321.33B
Revenue growth (YoY)+14.23%+9.31%
Net income (latest FY)$1.71B$1.55B
Gross margin3.84%3.57%
Operating margin1.03%0.82%
Net margin0.67%0.48%
52-week high$286.29$377.54
52-week low$180.45$244.82
Distance from 52-week high-4.71%-10.18%
Analyst consensusbuybuy
Avg. price target upside+8.09%+12.78%
Average volume1.72M1.29M
Shares outstanding231.14M190.83M
Employees58,78847,000
SectorHealth CareHealth Care
IndustryOther PharmaceuticalsOther Pharmaceuticals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CAH has outperformed COR by 37.5 percentage points over the past year.
  • Cardinal Health trades at a higher earnings multiple (35.3x vs 18.9x trailing P/E).

About Cardinal Health

CAH stock →

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.

Health Care · Other Pharmaceuticals · 58,788 employees

About Cencora

COR stock →

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.

Health Care · Other Pharmaceuticals · 47,000 employees

CAH vs COR FAQ

Which is bigger, Cardinal Health or Cencora?

Cencora (COR) is larger, with a market capitalization of $64.71B compared with $63.06B for Cardinal Health (CAH).

Which stock has performed better over the past year, CAH or COR?

CAH returned +30.23% over the past 12 months, compared with -7.27% for COR (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, CAH or COR?

COR has the lower trailing P/E at 18.9, versus 35.3 for CAH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Cardinal Health or Cencora?

Cardinal Health has the higher yield at 0.75%, compared with 0.71% for Cencora.

Are Cardinal Health and Cencora in the same industry?

Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.

More comparisons